Literature DB >> 19660385

Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach.

Patrick Montant1, Fabien Chenot, Annie Robert, David Vancraeynest, Agnès Pasquet, Bernard Gerber, Philippe Noirhomme, Gébrine El Khoury, Jean-Louis Vanoverschelde.   

Abstract

AIMS: The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair.
METHODS: One hundred ninety-two asymptomatic patients (mean age, 63 +/- 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years.
RESULTS: Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a "conservative approach" group (n = 67) and an "early surgery" group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% +/- 7% vs 86% +/- 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively.
CONCLUSION: Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.

Entities:  

Mesh:

Year:  2009        PMID: 19660385     DOI: 10.1016/j.jtcvs.2009.03.046

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  28 in total

1.  Asymptomatic mitral regurgitation-wait or operate?

Authors:  Christopher Cao; Sohaib Virk; Chloe Wilcox; Elan Novis; Hugh Wolfenden
Journal:  Ann Cardiothorac Surg       Date:  2015-07

Review 2.  Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies.

Authors:  J W Simpkins; S-H Yang; Y Wen; M Singh
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

3.  Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase.

Authors:  P Chiarugi; M L Taddei; G Ramponi
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 4.  [Modern mitral valve surgery].

Authors:  W Bothe; F Beyersdorf
Journal:  Internist (Berl)       Date:  2016-04       Impact factor: 0.743

5.  Is pulmonary artery pressure a trigger of adverse outcome in mitral regurgitation?

Authors:  Iside Scarfò; Giovanni La Canna
Journal:  Ann Transl Med       Date:  2016-12

Review 6.  Mitral regurgitation. Timing of surgery or interventional treatment.

Authors:  A Vahanian; B Iung
Journal:  Herz       Date:  2016-02       Impact factor: 1.443

Review 7.  Degenerative mitral valve regurgitation: best practice revolution.

Authors:  David H Adams; Raphael Rosenhek; Volkmar Falk
Journal:  Eur Heart J       Date:  2010-07-11       Impact factor: 29.983

8.  Single-centre experience with mitral valve repair in asymptomatic patients with severe mitral valve regurgitation.

Authors:  Wouter J van Leeuwen; Stuart J Head; Lotte E de Groot-de Laat; Marcel L Geleijnse; Ad J J C Bogers; Lex A Van Herwerden; A Pieter Kappetein
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-26

Review 9.  [Aftercare of patients after MitraClip® implantation].

Authors:  A Schlitt; E Lubos; M Guha; C Hegeler-Molkewehrum; M Sudau; H Schmidt
Journal:  Herz       Date:  2016-06-27       Impact factor: 1.443

Review 10.  The clinical anatomy and pathology of the human atrioventricular valves: implications for repair or replacement.

Authors:  Michael G Bateman; Jason L Quill; Alexander J Hill; Paul A Iaizzo
Journal:  J Cardiovasc Transl Res       Date:  2013-01-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.